Dr. Angeli Möller has two roles at Bayer Pharmaceuticals, she leads the artificial intelligence work stream and is responsible for the research digital investment strategy. Before joining Bayer she worked as a data scientist for translation medicine at Thomson Reuters and researcher at cancer research UK and the Max Delbrück Center for Molecular Medicine.
As keen proponent of pre-competitive collaboration she also sits on the executive committee of the Alliance for Artificial Intelligence in Healthcare (AAIH) and on the investment committee of the Pistoia Alliance.
Follow Angeli Moeller on LinkedIn.
